The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS)
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is one of the most common of all medical disorders worldwide and, while for some it represents no more than a nuisance, for others it imposes significant negative impacts on daily life and activities. IBS is a heterogeneous disorder and may well have a number of causes which may lie anywhere from the external environment to the contents of the gut lumen and from the enteric neuromuscular apparatus and the gut immune system to the central nervous system. Consequently, the paradigm of the gut-brain axis, which includes the participation of these various factors, has proven a useful model to assist clinicians and patients alike in understanding the genesis of symptoms in IBS. Now, given the widespread interest in the gut microbiome in health and disease, in general, reports of disordered enteric bacterial communities in IBS, and experimental data to indicate that components of the gut microbiota can influence brain morphology and function, as well as behavior and cognition, this concept has been extended to encompass the microbiota-gut-brain axis. The implications of this novel concept to the assessment and management of IBS will be explored in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“Other routes of influence, including the vagus nerve and microbial metabolites, have also been invoked [46] based on studies in animal models.”
BackgroundLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748
Gut feelings: the emerging biology of gut-brain communication
Mayer, E. A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3071 · Cited by 1,726 · cited 1×
“Interactions between brain and gut extend well beyond the bounds of the stressed, anxious or depressed gut and should also encompass situations where the brain, the gut and their linkage, through the autonomic nervous system, are affected by the same pathologic process, as in Parkinson’s disease (PD) as well as those…”
BackgroundConsumption of fermented milk product with probiotic modulates brain activity
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · cited 1×
“The limited data that is available is encouraging and suggests that, not only that the axis is operative, but also that its modulation may be therapeutically beneficial [49,50].”
BackgroundMicrobiota is essential for social development in the mouse
Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.65 · Cited by 866
Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F.-P., Cominetti, O., Welsh, C., Rieder, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.003 · Cited by 821
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Self-citationFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · cited 1×
“The poorly absorbed antibiotic rifaximin [39] and probiotics, in general [40], have been shown to ameliorate the cardinal symptoms of IBS.”
BackgroundSelf-citationThe neurobiology of stress and gastrointestinal disease
MAYER, E. A. (2000) · Gut · doi:10.1136/gut.47.6.861 · Cited by 666
Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642 · cited 2×
“Nonetheless, some overall patterns have emerged: the fecal and colonic mucosal microbiota are different in IBS [32] and the fecal microbiota may not only predict severity [34] but also responsiveness to one common intervention—the low fermentable oligosaccharide, disaccharide, Figure 1.”
BackgroundInflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568 · cited 1×
“Given the pro-inflammatory phenotype associated with depression, the aforementioned pro-inflammatory effects of a disrupted microbiome and the anti-inflammatory actions of some probiotics may be relevant here also; experimental evidence supports this concept [48].”
BackgroundThe brain-gut axis in abdominal pain syndromes.
Mayer, E. A., & Tillisch, K. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012309-103958 · Cited by 511
Klem, F., Wadhwa, A., Prokop, L. J., Sundt, W. J., Farrugia, G., Camilleri, M., Singh, S., & Grover, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.039 · Cited by 474 · cited 1×
“That the microbiota might be a factor in IBS [29,30] was first suggested by the observation that IBS could develop de novo in the aftermath of acute enteric bacterial, viral and parasitic infections [31].”
BackgroundFord, A. C., Spiegel, B. M. R., Talley, N. J., & Moayyedi, P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.031 · Cited by 351 · cited 2×
“Small intestinal bacteria might also play a role: though its precise prevalence and role in IBS remain uncertain, evidence has been presented to associate small intestinal bacterial overgrowth with IBS [36,37].”
BackgroundLuczynski, P., Whelan, S. O., O'Sullivan, C., Clarke, G., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13291 · Cited by 346
Sharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344 · cited 7×
“The rifaximin story may be more complicated than it would appear at first sight—its effects in IBS may not be dependent on the eradication of SIBO [42] or on the modulation of bacterial populations [43].”
BackgroundInfluentialThe Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335 · cited 3×
“Other roles for a disturbed microbiome or an aberrant host response to the microbiome, relevant to IBS, could also be invoked—the generation of intraluminal molecules with biological effects on gut function, impaired gut barrier function, immune activation and, of course communication with the central nervous system […”
BackgroundSelf-citationThe microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?
De Palma, G., Collins, S. M., Bercik, P., & Verdu, E. F. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273995 · Cited by 293 · cited 1×
“That the microbiota might be a factor in IBS [29,30] was first suggested by the observation that IBS could develop de novo in the aftermath of acute enteric bacterial, viral and parasitic infections [31].”
BackgroundYarandi, S. S., Peterson, D. A., Treisman, G. J., Moran, T. H., & Pasricha, P. J. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15146 · Cited by 293 · cited 1×
“Accordingly, the microbiome has emerged as a potential therapeutic target in disorders as diverse as IBS, Parkinson’s disease and depression [23,24].”
BackgroundLiu, H.-N., Wu, H., Chen, Y.-Z., Chen, Y.-J., Shen, X.-Z., & Liu, T.-T. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.142 · Cited by 254 · cited 4×
“Nonetheless, some overall patterns have emerged: the fecal and colonic mucosal microbiota are different in IBS [32] and the fecal microbiota may not only predict severity [34] but also responsiveness to one common intervention—the low fermentable oligosaccharide, disaccharide, Figure 1.”
BackgroundInfluentialMATTE, H. O., RODRIGUEZ, O. F., & CASTRO, E. A. (1955) · PubMed · Cited by 229
THE IRRITABLE BOWEL SYNDROME: A PAROXYSMAL MOTOR DISORDER
Kumar, D., & Wingate, D. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90525-2 · Cited by 225
Bennet, S. M. P., Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Öhman, L., & Simrén, M. (2018) · Gut · doi:10.1136/gutjnl-2016-313128 · Cited by 225
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · cited 1×
“While many other neuropsychiatric disorders including Alzheimer’s disease, amyotrophic lateral sclerosis, autism, stroke and drug addiction have been linked, in one way or another, to the microbiome [25], this review will briefly focus on IBS.”
BackgroundSelf-citationYamada' s Textbook of Gastroenterology
(2015) · Wiley eBooks · doi:10.1002/9781118512074 · Cited by 168
Tp, A., & Tulin, M. (1947) · PubMed · Cited by 163
Alterations in Colonic Function in Man Under Stress
Almy, T. P., Hinkle, L. E., Berle, B. B., & Kern, F. (1949) · Gastroenterology · doi:10.1016/s0016-5085(49)80126-0 · Cited by 153 · cited 1×
“This is not a new idea; the ability of the stressed brain to disturb colonic function was elegantly described by Almy and his colleagues 70 years ago [9].”
BackgroundImaging brain mechanisms in chronic visceral pain
Mayer, E. A., Gupta, A., Kilpatrick, L. A., & Hong, J.-Y. (2015) · Pain · doi:10.1097/j.pain.0000000000000106 · Cited by 143
The gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
Self-citationQuigley, E. M. M., Abdel-Hamid, H., Barbara, G., Bhatia, S. J., Boeckxstaens, G., De Giorgio, R., Delvaux, M., Drossman, D. A., Foxx-Orenstein, A. E., Guarner, F., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318247157c · Cited by 130
Self-citationThe Brain-Gut Axis in Health and Disease
Omran, Y. A., & Aziz, Q. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_6 · Cited by 126
Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Quigley, E. M. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.29 · Cited by 125 · cited 2×
“Currently available data are fraught with challenges in interpretation—small study populations, variations in patient selection and methodology not to mind the failure to account for such confounders as diet, therapy, co-morbid psychopathology and symptom severity [33].”
BackgroundSelf-citationBrain imaging of visceral functions in healthy volunteers and IBS patients
Rapps, N., Oudenhove, L. V., Enck, P., & Aziz, Q. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.02.018 · Cited by 117
Effect of psychological stress on salt and water transport in the human jejunum
Barclay, G. R., & Turnberg, L. A. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90319-2 · Cited by 111
Kellow, J. E., Langeluddecke, P. M., Eckersley, G. M., Jones, M. P., & Tennant, C. C. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011167 · Cited by 104
Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link
Ghoshal, U. C., & Gwee, K. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.37 · Cited by 86 · cited 2×
“Small intestinal bacteria might also play a role: though its precise prevalence and role in IBS remain uncertain, evidence has been presented to associate small intestinal bacterial overgrowth with IBS [36,37].”
BackgroundZeber-Lubecka, N., Kulecka, M., Ambrozkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., Rubel, T., Wojtowicz, W., Mlynarz, P., Marczak, L., et al. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1215805 · Cited by 78 · cited 2×
“The rifaximin story may be ore co plicated than it would appear at first sight—its effects in IBS may not be dependent on the er i n of SIBO [42] or on the modulation of bacterial populations [43].”
BackgroundSarna, S. K., Latimer, P. R., Campbell, D., & Waterfall, W. E. (1982) · Digestive Diseases and Sciences · doi:10.1007/bf01297213 · Cited by 58
Evidence for a cholecystokinin gut-brain axis with modulation by bombesin
Banks, W. A. (1980) · Peptides · doi:10.1016/0196-9781(80)90013-3 · Cited by 58 · cited 1×
“the enteric nervous system) was introduced to describe the central and peripheral effects of gut-brain peptides such as cholecystokinin and bombesin [6] and was soon implicated in disorders such as anorexia nervosa [7].”
BackgroundEffect of cold-induced pain on salt and water transport in the human jejunum
Barclay, G. R., & Turnberg, L. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90558-6 · Cited by 52
Sperber, A. D., Drossman, D. A., & Quigley, E. M. M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.106 · Cited by 43
Self-citationProbiotics in Irritable Bowel Syndrome: The Science and the Evidence
Quigley, E. M. M. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000348 · Cited by 41
Self-citationThe gut-brain brain-gut axis in anorexia: Toward an understanding of food intake regulation
Meguid, M., Yang, Z.-J., & Gleason, J. R. (1996) · Nutrition · doi:10.1016/0899-9007(96)90021-0 · Cited by 40
Stress and oesophageal motility in normal subjects and patients with irritable bowel syndrome.
Ayres, R. C., Robertson, D. A., Naylor, K., & Smith, C. L. (1989) · Gut · doi:10.1136/gut.30.11.1540 · Cited by 36
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
Kane, J. S., & Ford, A. C. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1140571 · Cited by 36 · cited 1×
“The poorly absorbed antibiotic rifaximin [39] and probiotics, in general [40], have been shown to ameliorate the cardinal symptoms of IBS.”
BackgroundThe Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34 · cited 2×
“Indeed, the model developed to explain the pathophysiology of HE; na ly, the conv rgence f small int stinal bacterial overgrowth (SIBO) and/or an abnormal microbiot , impaired gut b rrier function, a pro‐inflammatory st te and the ap ea ance in th systemic circulation of neuro‐ac ive mol cules ge erated by bacterial m…”
BackgroundMethodSoffer, E., Scalabrini, P., Pope, C. E., & Wingate, D. L. (1988) · Gut · doi:10.1136/gut.29.11.1591 · Cited by 30
The gut-brain brain-gut axis in anorexia: Toward an understanding of food intake regulation
Meguid, M. M., Yang, Z., & Gleason, J. R. (1996) · Nutrition · doi:10.1016/0899-9007(95)00083-6 · Cited by 30 · cited 1×
“the enteric nervous system) was introduced to describe the central and peripheral effects of gut-brain peptides such as cholecystokinin and bombesin [6] and was soon implicated in disorders such as anorexia nervosa [7].”
BackgroundBugs on the brain; brain in the gut—seeking explanations for common gastrointestinal symptoms
Quigley, E. M. M. (2012) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-012-0865-y · Cited by 27 · cited 1×
“That the microbiota might be a factor in IBS [29,30] was first suggested by the observation that IBS could develop de novo in the aftermath of acute enteric bacterial, viral and parasitic infections [31].”
BackgroundSelf-citationStudying the Brain–Gut Axis with Pharmacological Imaging
Tillisch, K., Wang, Z., Kilpatrick, L. A., Holschneider, D. P., & Mayer, E. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.025 · Cited by 22
The Microbiome and the Liver: The Basics
Victor, D., & Quigley, E. (2016) · Seminars in liver disease (Print) · doi:10.1055/s-0036-1593879 · Cited by 11 · cited 2×
“that modified gut bacterial populati n; a poorly a sorb d antibiotic, on the symptoms f is syn rome [26,27].”
BackgroundSelf-citationBird, L. (2015) · Nature reviews. Immunology · doi:10.1038/nri3882 · Cited by 10
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Black, C. J., & Ford, A. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0286-8 · Cited by 610
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Simon, E., Călinoiu, L. F., Mitrea, L., & Vodnar, D. C. (2021) · Nutrients · doi:10.3390/nu13062112 · Cited by 213
“However, there is a missing link in the precise differentiation of small intestinal bacterial overgrowth in IBS due to the current limitations of methodologies, such as jejunal aspiration and the breath test [11,159].”
Background
Metadata
- Authors
- Quigley, E.
- Affiliations
- Houston Methodist (US)
- Corresponding author
- Quigley, Eamonn
- ORCID
- Quigley, Eamonn
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-01-03
- Volume
- 7
- Issue
- 1
- Pages
- 6
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5791014
- OpenAlex
- W2781963884
- Semantic Scholar
- d793c9c7b988b71a9f0543b0a9db66da6b4ecfba
- Cited by
- 109
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 12 · 2023: 6 · 2022: 22 · 2021: 12 · 2020: 14 · 2019: 16 · 2018: 12
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, gut-brain axis, microbiota-gut-brain axis, gut microbiota, dysbiosis, enteric nervous system, gut immune system, IBS pathophysiology, IBS management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.